Zurich Stock Exchange: towards an attempt at recovery

Zurich Stock Exchange: towards an attempt at recovery
Zurich Stock Exchange: towards an attempt at recovery

Zurich (awp) – The Swiss Stock Exchange was moving towards a positive opening on Tuesday, after ending the first session of the week with significant losses. The indices across the Atlantic had closed in scattered order, awaiting indications on inflation in the United States. The results season was taking shape in Switzerland, notably with the preliminary performance of Lindt&Sprüngli.

“Investors are focusing on U.S. inflation data this week and new comments from Federal Reserve officials for fresh signals on central bank policy,”

Uncle Sam’s country must first take stock of its production and import prices (PPI) at the start of the afternoon, before delivering its official inflation statistics (CPI) on Wednesday. .

At 8:10 a.m., the pre-SMI concocted by Julius Bär predicted an increase of 0.52% to 11,762.34 points, in shades of green.

The asset manager Partners Group (+1.7%) was positioned at the forefront, which benefited from an increase in its price target by Goldman Sachs as a preamble to the presentation of the annual evolution of its assets under management (AuM), scheduled for the evening.

The defensive Swisscom (+0.3%) occupied the other end of the flagship index of the Zurich market.

Heavyweights Nestlé, Novartis and Roche all gained 0.4%.

-

Among mid-caps, Temenos (+3.5%) clearly stood out from the crowd. The Geneva-based banking software publisher issued a positive warning on results for the past financial year the evening before.

The industrial chocolate maker Lindt&Sprüngli (good +2.4%) followed not far away, which at dawn delivered a more convincing first glimpse of its 2024 performance than expected.

The dermato-cosmetic laboratory Galderma (+2.2%) completed the podium, in the wake of encouraging intermediate results around the use of aesthetic injectables on people who have experienced significant medically induced weight loss.

The only stock listed in the red, the specialty chemist Clariant (-2.1%) was implicated by the German sector behemoth BASF in a cartel case. An implication that the Rhine group disputes.

jh/vj

-

--

PREV The European Anti-Torture Committee denounces police practices in French-speaking Switzerland
NEXT Where is Maraya? An investigation into “disturbing disappearance” opened